Guardant Health
GH
#3260
Rank
โ‚ฌ3.41 B
Marketcap
27,61ย โ‚ฌ
Share price
-3.64%
Change (1 day)
34.01%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -4,68ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -4,66ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -6,07ย โ‚ฌ a decrease over its 2021 EPS that were of -3,79ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,68ย โ‚ฌ-22.83%
2022-6,07ย โ‚ฌ60%
2021-3,79ย โ‚ฌ55.04%
2020-2,45ย โ‚ฌ207.14%
2019-0,80ย โ‚ฌ-19.81%
2018-0,99ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-4,57ย โ‚ฌ-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,11ย โ‚ฌ-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA